Antibiotic susceptibility pattern of strains of Campylobacter coli isolated in Osogbo, Nigeria

Biology and Medicine

Volumn 1, Issue 1, 2009, Pages 20-23

  Adekunle, O C ^a   Coker, A O ^b   Kolawole, D O ^c  

^a LADOKE AKINTOLA UNIVERSITY OF TECHNOLOGY   (Nigeria)

^b UNIVERSITY OF LAGOS   (Nigeria)

^c OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

Author keywords

Antibiotics; Antimicrobial; Campylobacter; Gastroenteritis; Susceptibility

Indexed keywords

CAMPYLOBACTER; CAMPYLOBACTER COLI;

EID: 79952635529     PISSN: None     EISSN: 09748369     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Aarestrup FM, Nielson EM, Madsen M, Engberg J, 1997. Antimicrobial susceptibility patterns of thermophilic campylobacter species from humans, pigs, cattle, and broilers in Denmark. Antimicrobial Agents and Chemotherapy, 41: 2244-2250. http://aac.asm.org/cgi/content/abstract/41/10/2244
2. Coker AO, Adefeso AO, 1995. The changing pattern of Campylobacter jejuni/coli in Lagos, Nigeria after 10 years. East African Medical Journal, 71: 437-440.
3. Coker AO, Olukoya DK, Odegbemi T, 1988. Antibiotics susceptibility patterns and betalactamase production of strains of campylobacter species isolated in Nigeria. Proceedings of the 4th International Workshop on Campylobacter Infections, Goteborg, held in Sweden. Edited by Kaijser B and Failsen E. Published by Gotherma Kungaly, Sweden 1988, pp 153-154.
4. Dupont HI, Ericsson CD, Robison A, Johnson PC, 1987. Current problems in antimicrobial therapy for bacterial enteric infection. American Journal of Medicine, 82: 324 - 328.
5. Ellis-Pegler RB, Hyman LK, Ingram RJ, McCarthy MA, 1995. Placebo controlled evaluation of lomefloxacin in the treatment of bacterial diarrhea in the community. Journal of Antimicrobial Chemotherapy, 36: 259-263.
6. Engberg J, Harestrup FM, Taylor DE, Gerner-Smidt P, Nachmakin I, 2007. Quinolone and macrolide resistance in Campylobacter jejuni and C. coli resistance and trends isolated in humans. Emerging Infectious Diseases, 7: 24-34. http://www.cdc.gov/eid/content/13/7/pdfs/vol13no07.pdf
7. Hoge CW, Gambel JM, Srijan A, Pitarangsi C, Echeverria P, 1998. Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years. Clinical Infectious Diseases, 26: 341-345.
8. Huang MB, Baker CN, Banerjee S, Tenover FC, 1992. Accuracy of the E-test for determining antimicrobial susceptibilities of staphylococci, enterococci, Campylobacter jejuni, and gramnegative bacteria resistant to antimicrobial agents. Journal of Clinical Microbiology, 30: 3243-3248. http://jcm.asm.org/cgi/content/abstract/30/12/3243
9. Lachance N, Gaudreau C, Lamothe F, Lariviera LA, 1991. Role of the beta-lactamase of Campylobacter jejuni in resistance to beta-lactamase agents. Antimicrobial Agents and Chemotherapy, 35: 813-818. http://aac.asm.org/cgi/content/abstract/35/5/813
10. Lachance N, Gaudreau C, Lamothe F, Turgelon F, 1993. Susceptibilities of beta-lactamase positive and negative strains of Campylobacter coli to Blactam agents. Antimicrobial Agents and Chemotherapy, 37: 1174-1176. http://aac.asm.org/cgi/reprint/37/5/1174
11. Reina J, Borrell N, Serra A, 1995. Emergence of resistance to erythromycin and fluoroquinolone in thermotolerant campylobacter strains isolated from faeces between 1987 and 1991. European Journal of Clinical Microbiology and Infectious Diseases, 11: 1163-1166.
12. Sjogren E, Kaljser B, Werner M, 1992. Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report. Antimicrobial Agents and Chemotherapy, 36: 2847-2849. http://aac.asm.org/cgi/content/abstract/36/12/2847
13. Tee N, Mijch A, 1998. Campylobacter jejuni bacteremia in human immunodeficiency virus (HIV)-infected and non-HIV-infected patients: comparison of clinical features and review. Clinical Infectious Diseases, 26: 91-96. http://www.journals.uchicago.edu/doi/pdf/10.1086/517748